18F-氟胆碱PET/CT在原发性甲状旁腺功能亢进症中的诊断性能优于传统闪烁显像
该研究纳入103例原发性甲状旁腺功能亢进症(PHPT)患者,术前分别行18F-氟胆碱PET/CT与传统闪烁显像(99mTc-甲氧异腈SPECT/CT、减影成像及双相成像),以组织学及术后第1天和随访的完整甲状旁腺激素与血清钙为标准,发现PET/CT定位功能亢进甲状旁腺的灵敏度显著高于传统方法。
要点
- 18F-氟胆碱PET/CT术前定位功能亢进甲状旁腺的灵敏度为92%,传统显像为39%-56%。
- 多发功能亢进腺体亚组中PET/CT灵敏度为88%,传统显像仅22%-34%。
- PET/CT可提高术前准确定位,有助于实施聚焦性手术。
核心结论
- 18F-氟胆碱PET/CT在PHPT患者中诊断性能优于传统闪烁显像,可实现准确的术前定位。
研究设计与样本
- 研究纳入103例PHPT患者,术前均行18F-氟胆碱PET/CT及传统闪烁显像(99mTc-甲氧异腈SPECT/CT、减影成像、双相成像),以组织学及术后第1天和随访的完整甲状旁腺激素与血清钙为标准评估影像结果。
主要发现
- 全部患者中,18F-氟胆碱PET/CT的灵敏度为92%,传统显像各方法为39%-56%,联合为65%。
- 亚组分析显示,多发功能亢进腺体组PET/CT灵敏度为88%,传统显像为22%-34%(联合44%)。
关键数值与推荐
- 全部患者中PET/CT灵敏度92%,传统显像各方法39%-56%,联合65%。
- 多发功能亢进腺体亚组中PET/CT灵敏度88%,传统显像22%-34%,联合44%。
临床怎么用
- 对于PHPT患者,术前可采用18F-氟胆碱PET/CT定位功能亢进甲状旁腺,尤其适用于多发腺体病变者,以支持聚焦性手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary hyperparathyroidism (PHPT) is a common endocrine disorder, definitive treatment usually requiring surgical removal of the offending parathyroid glands. To perform focused surgical approaches, it is necessary to localize all hyperfunctioning glands. The aim of the study was to compare the efficiency of established conventional scintigraphic imaging modalities with emerging 18F-fluorocholine PET/CT imaging in preoperative localization of hyperfunctioning parathyroid glands in a larger series of PHPT patients. Methods: In total, 103 patients with PHPT were imaged preoperatively with 18F-fluorocholine PET/CT and conventional scintigraphic imaging methods, consisting of 99mTc-sestamibi SPECT/CT, 99mTc-sestamibi/pertechnetate subtraction imaging, and 99mTc-sestamibi dual-phase imaging. The results of histologic analysis, as well as intact parathyroid hormone and serum calcium values obtained 1 d after surgery and on follow-up, served as the standard of truth for evaluation of imaging results. Results: Diagnostic performance of 18F-fluorocholine PET/CT surpassed conventional scintigraphic methods (separately or combined), with calculated sensitivity of 92% for PET/CT and 39%-56% for conventional imaging (65% for conventional methods combined) in the entire patient group. Subgroup analysis, differentiating single and multiple hyperfunctioning parathyroid glands, showed PET/CT to be most valuable in the group with multiple hyperfunctioning glands, with sensitivity of 88%, whereas conventional imaging was significantly inferior, with sensitivity of 22%-34% (44% combined). Conclusion:18F-fluorocholine PET/CT is a diagnostic modality superior to conventional imaging methods in patients with PHPT, allowing for accurate preoperative localization.
引用
- Cuderman A, Senica K, Rep S, et al. 18F-Fluorocholine PET/CT in Primary Hyperparathyroidism: Superior Diagnostic Performance to Conventional Scintigraphic Imaging for Localization of Hyperfunctioning Parathyroid Glands. J Nucl Med. 2019. PMID: 31562221. doi:10.2967/jnumed.119.229914
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。